DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Sanofi India Limited — Change in Management

NSE 1 hr ago·23 Jul 2026, 5:00 am

Sanofi India

Sanofi India has announced a change in its senior management team, with the company informing stock exchanges about the transition. This move involves the appointment of a new Chief Executive Officer, marking a shift in the company's leadership structure.

For investors, this development is significant as it signals a potential strategic pivot or a new direction for the company's operations. While the immediate financial impact is likely minimal, it is a key event to monitor as it may influence the company's future growth plans and market strategy.

Investors should watch for the new CEO's strategic vision and any comments regarding the company's roadmap. It is also important to observe how the market reacts to the news and whether this leadership change brings any new opportunities or challenges for the stock.